文献速递慢性肾脏病

不确定潜能的克隆性造血与糖尿病肾脏病:一项巢式病例对照研究

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study.
PubMed 文献 · Kidney Int Rep · 2022-02-03

基于PROVALID研究的1419名参与者,采用巢式病例对照设计,64例达到复合终点者匹配4名对照共294人,分析不确定潜能的克隆性造血(CHIP)与糖尿病肾脏病(DKD)发生或进展的关联。CHIP估计患病率为28.91%(95%CI 22.91%-34.91%),CHIP与DKD发生或进展无关(HR 1.06,95%CI 0.57-1.96);而白蛋白尿、糖化血红蛋白、心力衰竭、吸烟及微炎症升高与肾功能下降相关。

要点

  • 在2型糖尿病人群中,CHIP估计患病率为28.91%(95%CI 22.91%-34.91%)。
  • CHIP与DKD发生或进展无关(HR 1.06,95%CI 0.57-1.96)。
  • 白蛋白尿、糖化血红蛋白、心力衰竭、吸烟及微炎症升高与肾功能下降相关。

核心结论

  • 在这项巢式病例对照研究中,常见危险因素及微炎症升高与2型糖尿病患者的肾功能下降相关,而CHIP与DKD发生或进展无关。

研究设计与样本

  • 基于PROVALID研究的1419名合格参与者,采用巢式病例对照设计。
  • 观察期内64名达到预设复合终点(启动肾脏替代治疗、肾脏衰竭死亡、估算肾小球滤过率持续下降40%或持续进展为大量白蛋白尿)的参与者,按1:4匹配对照,巢式病例对照样本共294人。
  • 通过外周血46个基因的靶向扩增子测序评估CHIP,并通过多重检测分析血浆炎症细胞因子。

主要发现

  • CHIP估计患病率为28.91%(95%CI 22.91%-34.91%)。
  • 与其他已知危险因素(白蛋白尿、糖化血红蛋白、心力衰竭、吸烟)及微炎症升高不同,CHIP与DKD发生或进展无关(HR 1.06,95%CI 0.57-1.96)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The disease trajectory of diabetic kidney disease (DKD) shows a high interindividual variability not sufficiently explained by conventional risk factors. Clonal hematopoiesis of indeterminate potential (CHIP) is a proposed novel cardiovascular risk factor. Increased kidney fibrosis and glomerulosclerosis were described in mouse models of CHIP. Here, we aim to analyze whether CHIP affects the incidence or progression of DKD. METHODS: A total of 1419 eligible participants of the PROVALID Study were the basis for a nested case-control (NCC) design. A total of 64 participants who reached a prespecified composite endpoint within the observation period (initiation of kidney replacement therapy, death from kidney failure, sustained 40% decline in estimated glomerular filtration rate or sustained progression to macroalbuminuria) were identified and matched to 4 controls resulting in an NCC sample of 294 individuals. CHIP was assessed via targeted amplicon sequencing of 46 genes in peripheral blood. Furthermore, inflammatory cytokines were analyzed in plasma via a multiplex assay. RESULTS: The estimated prevalence of CHIP was 28.91% (95% CI 22.91%-34.91%). In contrast to other known risk factors (albuminuria, hemoglobin A1c, heart failure, and smoking) and elevated microinflammation, CHIP was not associated with incident or progressive DKD (hazard ratio [HR] 1.06 [95% CI 0.57-1.96]). CONCLUSIONS: In this NCC study, common risk factors as well as elevated microinflammation but not CHIP were associated with kidney function decline in type 2 diabetes mellitus.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Denicolò S, Vogi V, Keller F, et al. Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study. Kidney Int Rep. 2022. PMID: 35497780. doi:10.1016/j.ekir.2022.01.1064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。